Express Scripts Announces Strategic Partnership with Centene to Unlock Greater Prescription Drug Savings

Go back to Express Scripts Announces Strategic Partnership with Centene to Unlock Greater Prescription Drug Savings

Centene (CNC) PT Lowered to $108 at Jefferies

October 26, 2022 7:57 AM EDT

Jefferies analyst David Windley lowered the price target on Centene (NYSE: CNC) to $108.00 (from $116.00) while maintaining a Buy rating.

The analyst commented, "A mostly in-line 3Q was uplifted by mgt's confidence that incremental positives (VCP, inv inc, new PBM contract) can offset... More